Analgesic efficacy of Tenoxicam,Nalbuphine and Magnesium sulphate as adjuvant to intraarticular Levobupivacaine in knee art
Not Applicable
- Conditions
- Musculoskeletal DiseasesSurgeryknee arthroscopy
- Registration Number
- PACTR201704002155170
- Lead Sponsor
- Hatem Elmoutaz
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 90
Inclusion Criteria
Male patients
-Age 18-50 years
Exclusion Criteria
Patients will be excluded from the study if they had sickle cell disease, peripheral vascular disease, history of DVT, poorly controlled hypertension, history of allergy to the studied drug, treatment for chronic pain alcohol and substance addiction chronic use of NSAID, opiates
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method